183 related articles for article (PubMed ID: 31567487)
1. Predictive Value of Sentinel Lymph Node Biopsy in Cutaneous Squamous Cell Carcinoma Based on the AJCC-8 and Brigham and Women's Hospital Staging Criteria.
Tejera-Vaquerizo A; Cañueto J; Llombart B; Martorell-Calatayud A; Sanmartín O
Dermatol Surg; 2020 Jul; 46(7):857-862. PubMed ID: 31567487
[TBL] [Abstract][Full Text] [Related]
2. Staging for cutaneous squamous cell carcinoma as a predictor of sentinel lymph node biopsy results: meta-analysis of American Joint Committee on Cancer criteria and a proposed alternative system.
Schmitt AR; Brewer JD; Bordeaux JS; Baum CL
JAMA Dermatol; 2014 Jan; 150(1):19-24. PubMed ID: 24226651
[TBL] [Abstract][Full Text] [Related]
3. Stratification of Poor Outcomes for Cutaneous Squamous Cell Carcinoma in Immunosuppressed Patients Using the American Joint Committee on Cancer Eighth Edition and Brigham and Women's Hospital Staging Systems.
Blechman AB; Carucci JA; Stevenson ML
Dermatol Surg; 2019 Sep; 45(9):1117-1124. PubMed ID: 30640779
[TBL] [Abstract][Full Text] [Related]
4. Validating 4 Staging Systems for Cutaneous Squamous Cell Carcinoma Using Population-Based Data: A Nested Case-Control Study.
Roscher I; Falk RS; Vos L; Clausen OPF; Helsing P; Gjersvik P; Robsahm TE
JAMA Dermatol; 2018 Apr; 154(4):428-434. PubMed ID: 29516080
[TBL] [Abstract][Full Text] [Related]
5. Comparing the eighth and the seventh editions of the American Joint Committee on Cancer staging system and the Brigham and Women's Hospital alternative staging system for cutaneous squamous cell carcinoma: Implications for clinical practice.
Cañueto J; Burguillo J; Moyano-Bueno D; Viñolas-Cuadros A; Conde-Ferreirós A; Corchete-Sánchez LA; Pérez-Losada J; Román-Curto C
J Am Acad Dermatol; 2019 Jan; 80(1):106-113.e2. PubMed ID: 30003984
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the American Joint Committee on Cancer Seventh Edition and Brigham and Women's Hospital Cutaneous Squamous Cell Carcinoma Tumor Staging in Immunosuppressed Patients.
Gonzalez JL; Cunningham K; Silverman R; Madan E; Nguyen BM
Dermatol Surg; 2017 Jun; 43(6):784-791. PubMed ID: 28079640
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous squamous cell carcinoma staging may influence management in users: A survey study.
Patel VA; McCullum C; Sparks AD; Schmults CD; Arron ST; Jambusaria-Pahlajani A
Cancer Med; 2022 Jan; 11(1):94-103. PubMed ID: 34796670
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women's Hospital tumor staging for cutaneous squamous cell carcinoma.
Karia PS; Jambusaria-Pahlajani A; Harrington DP; Murphy GF; Qureshi AA; Schmults CD
J Clin Oncol; 2014 Feb; 32(4):327-34. PubMed ID: 24366933
[TBL] [Abstract][Full Text] [Related]
9. Performance of the American Joint Committee on Cancer Staging Manual, 8th Edition vs the Brigham and Women's Hospital Tumor Classification System for Cutaneous Squamous Cell Carcinoma.
Ruiz ES; Karia PS; Besaw R; Schmults CD
JAMA Dermatol; 2019 Jul; 155(7):819-825. PubMed ID: 30969315
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Tumor Staging: Predicting Nodal Metastases in Cutaneous Squamous Cell Carcinoma.
Upton M; Kita A; Scapa J; St John M
Laryngoscope; 2021 Jan; 131(1):E170-E175. PubMed ID: 32212346
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node biopsy for head and neck cutaneous squamous cell carcinoma using the Brigham and Women's staging system: a cost analysis.
Quinn PL; Kim JK; Prasath V; Panse N; Knackstedt TJ; Chokshi RJ
Arch Dermatol Res; 2023 Apr; 315(3):371-378. PubMed ID: 35303163
[TBL] [Abstract][Full Text] [Related]
12. Systematic review of the prevalence of nodal metastases and the prognostic utility of sentinel lymph node biopsy in cutaneous squamous cell carcinoma.
Tejera-Vaquerizo A; García-Doval I; Llombart B; Cañueto J; Martorell-Calatayud A; Descalzo-Gallego MA; Sanmartín O
J Dermatol; 2018 Jul; 45(7):781-790. PubMed ID: 29701281
[TBL] [Abstract][Full Text] [Related]
13. American Joint Committee on Cancer clinical stage as a selection criterion for sentinel lymph node biopsy in thin melanoma.
Vaquerano J; Kraybill WG; Driscoll DL; Cheney R; Kane JM
Ann Surg Oncol; 2006 Feb; 13(2):198-204. PubMed ID: 16418885
[TBL] [Abstract][Full Text] [Related]
14. Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients.
Rousseau DL; Ross MI; Johnson MM; Prieto VG; Lee JE; Mansfield PF; Gershenwald JE
Ann Surg Oncol; 2003 Jun; 10(5):569-74. PubMed ID: 12794025
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system.
Jambusaria-Pahlajani A; Kanetsky PA; Karia PS; Hwang WT; Gelfand JM; Whalen FM; Elenitsas R; Xu X; Schmults CD
JAMA Dermatol; 2013 Apr; 149(4):402-10. PubMed ID: 23325457
[TBL] [Abstract][Full Text] [Related]
16. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention.
Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Fargnoli MC; Forsea AM; Frenard C; Harwood CΑ; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NW; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
Eur J Cancer; 2020 Mar; 128():60-82. PubMed ID: 32113941
[TBL] [Abstract][Full Text] [Related]
17. Performance of Salamanca refinement of the T3-AJCC8 versus the Brigham and Women's Hospital and Tübingen alternative staging systems for high-risk cutaneous squamous cell carcinoma.
Puebla-Tornero L; Corchete-Sánchez LA; Conde-Ferreirós A; García-Sancha N; Corchado-Cobos R; Román-Curto C; Cañueto J
J Am Acad Dermatol; 2021 Apr; 84(4):938-945. PubMed ID: 33333151
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of Sentinel Lymph Node Biopsy for Primary Cutaneous Squamous Cell Carcinoma of the Head and Neck.
Pride RLD; Lopez JJ; Brewer JD; Price DL; Otley CC; Roenigk RK; Arpey CJ; Baum CL
Dermatol Surg; 2022 Feb; 48(2):157-161. PubMed ID: 34889209
[TBL] [Abstract][Full Text] [Related]
19. Metastatic Cutaneous Squamous Cell Carcinoma: The Importance of T2 Stratification and Hematologic Malignancy in Prognostication.
Stevenson ML; Kim R; Meehan SA; Pavlick AC; Carucci JA
Dermatol Surg; 2016 Aug; 42(8):932-5. PubMed ID: 27467226
[TBL] [Abstract][Full Text] [Related]
20. Impact of Gene Expression Profile Testing on the Management of Squamous Cell Carcinoma by Dermatologists.
Rebeca T; Giselle P; Litchman GH; Rigel DS
J Drugs Dermatol; 2019 Oct; 18(10):980-984. PubMed ID: 31584775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
